搜索临床试验以:ALA Dehydratase Deficient Porphyria (ADP)
总计60237个结果
-
University of Texas Southwestern Medical Center撤销
-
Korea University Anam HospitalTakeda; Korean Cancer Study Group尚未招聘
-
National University Hospital, Singapore招聘中
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UK招聘中
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZeneca完全的
-
Australia New Zealand Gynaecological Oncology GroupBeiGene撤销
-
Wuhan University尚未招聘
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological Oncology主动,不招人
-
AstraZeneca完全的
-
National Cancer Institute, Naples招聘中
-
Peter MacCallum Cancer Centre, Australia招聘中
-
Tango Therapeutics, Inc.终止乳腺癌 | 卵巢癌 | 前列腺癌 | 胰腺癌 | BRCA1突变 | BRCA-突变的卵巢癌 | BRCA 相关性乳腺癌 | HRD 阳性晚期卵巢癌美国
-
BayerGlaxoSmithKline终止
-
Institut BergoniéNational Cancer Institute, France完全的
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United Kingdom完全的
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical Center招聘中
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
PfizerMedivation, Inc.完全的
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.尚未招聘BRCA1突变 | BRCA2突变 | PALB2基因突变 | 激素受体阳性 HER-2 阴性乳腺癌 | 晚期或转移性乳腺癌德国
-
Nader SanaiGlaxoSmithKline; University of California, San Francisco; Barrow Neurological Institute; Ivy Brain...招聘中
-
Massachusetts General HospitalTesaro, Inc.招聘中
-
Gustave Roussy, Cancer Campus, Grand Paris暂停
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang University; Taizhou...尚未招聘三阴性乳腺癌 | 同源重组缺陷
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.主动,不招人
-
AbbVie不再可用高级别浆液性卵巢癌 | 具有记录在案的 BRCA、BARD 或 PALB 或其他科学上合理的可接受的 DNA 突变或异常的实体瘤 | 三阴性乳腺癌 (TNBC) | 需要 Veliparib 混悬剂的患者
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust未知
-
Sunnybrook Health Sciences CentreGlaxoSmithKline招聘中